Back on topic!
The compound in questions is also known under the codes "FLA 289" and 4-DMAA. It is a MAO-inhibitor, being quite MAO-A-selective:
in vitro
IC50 (MAO-A) = 3.7 µM
IC50 (MAO-B) = 400 µM
in vivo
EC50 (intra-neuronal, p.o.) = 2.5 µmol/kg
EC50 (extra-neuronal, p.o.= 30 µmol/kg
rat hypothalamus
Hence, it shares the hazards of other combined low-to-medium-potency stimulants / MAO-inhibitors. Being both agent and inhibitor of its own metabolism is not exactly what I consider as safe to use.
Ref:
Br J Pharm 1985,
85, p.683; see also
Biochem Pharmacol 1994,
47(8), p.1365.
The compound is also a moderate 5HT-reuptake inhibitor with a IC50 of 1.1 µM in hypothalamic synaptosomes resp. 0.32 µM (same, but reserpine-pretreated).
Ref:
Naunyn-Schmiedeberg Arch Pharmacol 1987,
336, p.591
No big surprise, considering the abovementioned properties, the compound is anorexic.
Ref:
J Med Chem 1963,
6(5), p.519.
Conclusion: Most probably active, mainly as stimulant. Moderate potency. Not the safest to use.
Peace!
Murphy